• Time to Entry for New Cancer Medicines- From European Union–Wide Marketing Authorization to Patient Access in Belgium, Estonia, Scotland, and Sweden

    Jul 1, 2018, 00:00

  • Long-Term Health and Economic Value of Improved Mobility among Older Adults in the United States

    Jul 1, 2018, 00:00

  • Informing a priori Sample Size Estimation in Qualitative Concept Elicitation Interview Studies for Clinical Outcome Assessment Instrument Development

    Jul 1, 2018, 00:00

  • Table of Contents

    Jul 1, 2018, 00:00

  • Economic Burden of Cardiovascular Disease in Type 2 Diabetes- A Systematic Review

    Jul 1, 2018, 00:00

  • Value of External Data in the Extrapolation of Survival Data- A Study Using the NJR Data Set

    Jul 1, 2018, 00:00

  • Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries- Trends in Cost-per-DALY Studies

    Jul 1, 2018, 00:00

  • Best Methods of Communicating Clinical Trial Data to Improve Understanding of Treatments for Patients with Multiple Sclerosis

    Jul 1, 2018, 00:00

  • Critical Analysis of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening- A Systematic Review

    Jul 1, 2018, 00:00

  • A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer—Reply to letter to the editor by Petelin et al.

    Jul 1, 2018, 00:00

  • Effect of Level Overlap and Color Coding on Attribute Non-Attendance in Discrete Choice Experiments

    Jul 1, 2018, 00:00

  • What Characteristics of Nursing Homes Are Most Valued by Consumers? A Discrete Choice Experiment with Residents and Family Members

    Jul 1, 2018, 00:00

  • Cost-Effectiveness Analysis in Telehealth- A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management

    Jul 1, 2018, 00:00

  • Instructions for Authors

    Jul 1, 2018, 00:00

  • Personalized Mammography Screening and Screening Adherence—A Simulation and Economic Evaluation

    Jul 1, 2018, 00:00

  • Copyright/Subscription

    Jul 1, 2018, 00:00

  • Editorial Board

    Jul 1, 2018, 00:00

  • Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients- Evidence from the PITER Real-World Cohort

    Jul 1, 2018, 00:00

  • Medical Treatments for Acromegaly- A Systematic Review and Network Meta-Analysis

    Jul 1, 2018, 00:00

  • Computer Modeling of Diabetes and Its Transparency- A Report on the Eighth Mount Hood Challenge

    Jun 1, 2018, 00:00

  • Copyright/Subscription

    Jun 1, 2018, 00:00

  • A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United Kingdom

    Jun 1, 2018, 00:00

  • Effect of Crossover in Oncology Clinical Trials on Evidence Levels in Early Benefit Assessment in Germany

    Jun 1, 2018, 00:00

  • Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making- Recommendations from the ePRO Consortium

    Jun 1, 2018, 00:00

  • Building Synergy between Regulatory and HTA Agencies beyond Processes and Procedures—Can We Effectively Align the Evidentiary Requirements? A Survey of Stakeholder Perceptions

    Jun 1, 2018, 00:00

  • State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015

    Jun 1, 2018, 00:00

  • Core Items for a Standardized Resource Use Measure- Expert Delphi Consensus Survey

    Jun 1, 2018, 00:00

  • Editorial Board

    Jun 1, 2018, 00:00

  • Experiences of Structured Elicitation for Model-Based Cost-Effectiveness Analyses

    Jun 1, 2018, 00:00

  • Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities- A French Cluster Randomized Controlled Trial

    Jun 1, 2018, 00:00

  • Expert Elicitation of Multinomial Probabilities for Decision-Analytic Modeling- An Application to Rates of Disease Progression in Undiagnosed and Untreated Melanoma

    Jun 1, 2018, 00:00

  • Development of Methods for the Mapping of Utilities Using Mixture Models- Mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in Patients with Asthma

    Jun 1, 2018, 00:00

  • Agreement among the Productivity Components of Eight Presenteeism Tests in a Sample of Health Care Workers

    Jun 1, 2018, 00:00

  • Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures- Summary of an FDA and Critical Path Institute Workshop

    Jun 1, 2018, 00:00

  • Evaluation of Split Version and Feedback Module on the Improvement of Time Trade-Off Data

    Jun 1, 2018, 00:00

  • A Transparent and Consistent Approach to Assess US Outpatient Drug Costs for Use in Cost-Effectiveness Analyses

    Jun 1, 2018, 00:00

  • Table of Contents

    Jun 1, 2018, 00:00

  • The 2018 US Payor Landscape- Trends And Results from Formulary Management Surveys

    May 1, 2018, 00:00

  • Gastrointestinal Risk Factors and Patient-Reported Outcomes in Ankylosing Spondylitis of Korea

    May 1, 2018, 00:00

  • A Systematic Literature Review of the Metholodigcal Approaches and Conclusions from Published Cost-Effectiveness Models in the Treatment of Aggressive B-Cell Lymphomas

    May 1, 2018, 00:00

  • Long-Term Users of Benzodiazepines in Colombia- Patterns of use and Cessation of Treatment

    May 1, 2018, 00:00

  • Impact of Medicaid Treatment Access Policies on the Hepatitis C Epidemic

    May 1, 2018, 00:00

  • Disparity in Receiving Diagnostic Workup and Treatment Among Children with Refractory Epilepsy

    May 1, 2018, 00:00

  • Treatment Outcome Priorities for Youth with Multi-Morbid Mental Health Conditions- A Latent Class Analysis of a Best-Worst Scaling Experiment

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Myostrain in the Early Detection of Heart Failure Patients

    May 1, 2018, 00:00

  • Challenges to Reducing Low-Value Care- Lessons Learned and Future Directions

    May 1, 2018, 00:00

  • Examining Costs, Utilization, and Driving Factors of Complementary and Alternative Medicine (CAM) Services

    May 1, 2018, 00:00

  • Cost-Utility Analysis Comparing Abobotulinumtoxina with Onabotulinumtoxina for the Treatment of Pediatric Lower Limb Spasticity

    May 1, 2018, 00:00

  • How Values Inform the Health Policy Decision-Making Processes About Health-System Financing in Latin America? A Critical Interpretive Synthesis

    May 1, 2018, 00:00

  • Economic Evaluation of the Mobile Electron Accelerator for Intraoperative Radiotherapy in Patients with Breast Cancer

    May 1, 2018, 00:00

  • Treatment Strategies in Children with Severe Sickle Cell Disease after the Introduction of L-Glutamine Powder- A Decision Analysis

    May 1, 2018, 00:00

  • Efficacy and Safety of Biosimilar Insulins Compared to Their Reference Products- A Systematic Review

    May 1, 2018, 00:00

  • Differences in HPV Vaccine Uptake by Nativity Status Among American Men Aged 18-32

    May 1, 2018, 00:00

  • Development of a Patient-Reported Outcome (PRO) Instrument for Patients with Acquired Thrombotic Thrombocytopenic Purpura

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Liraglutide Versus Insulin Glargine in Chinese Patients with Type 2 Diabetes Insufficiently Controlled on Metformin

    May 1, 2018, 00:00

  • The Evaluation of Adherence to Treatment and Real-World Outcomes in Two Cohorts of Patients with Serious Mental Illness (SMI)

    May 1, 2018, 00:00

  • Metformin use and the Risk of Breast, Ovarian, Endometrial, and Cervical Cancers in Elderly Females in the USA

    May 1, 2018, 00:00

  • Cost Effectiveness of Tobramycin Versus Azithromycin as First-Line Therapy for Acute Exacerbations Among Patients with Non-Cystic Fibrosis Bronchiectasis

    May 1, 2018, 00:00

  • Economic Burden of Myasthenia Gravis in the US- A Literature Review

    May 1, 2018, 00:00

  • Agreement Between FDA Approved Drug Label and Performance-Based Risk-Sharing Arrangement Endpoints

    May 1, 2018, 00:00

  • The Economic Burden of Mechanically Ventilated Patients with Pneumonia in the US

    May 1, 2018, 00:00

  • Relationship Between Health State And Patient Reported Outcome In Cutaneous T-Cell Lymphoma- An Exploratory Analysis

    May 1, 2018, 00:00

  • The Past, Present and Future of Multi-Criteria Decision Analysis (MCDA) Applied in Medical Field

    May 1, 2018, 00:00

  • Impact of Biosmilars on the Price and Access of Originators in Major Autoimmune Indications- An Eu5 Perspective

    May 1, 2018, 00:00

  • A Study of Peripheral Lower-Extremity Diseases-Related Hospitalization Discharge Status and its Association with Diabetes Using a US National Database

    May 1, 2018, 00:00

  • Analysis of Sociodemographic Determinants of Adverse Drug Events- Using the National Inpatient Sample Database

    May 1, 2018, 00:00

  • Risk of Subsequent Migraine Events after Treating Migraine with Opioids Among Mississippi Division of Medicaid Beneficiaries

    May 1, 2018, 00:00

  • Patient Reported Treatment Satisfaction With Palbociclib Combination Therapies For HR+/HER2– Advanced Or Metastatic Breast Cancer In Multiple Countries

    May 1, 2018, 00:00

  • The Effect of Patient-Centered Oncology Care on Healthcare Utilization and Cost- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Benchmarking HIV Quality Measures Across US Payer Types

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Umeclidinium Bromide/Vilanterol 62.5/25 MCG Versus Tiotropium/Olodaterol 5/5 MCG in Symptomatic Patients with Chronic Obstructive Pulmonary Disease in Spain

    May 1, 2018, 00:00

  • Use of Multiple Concurrent Antipsychotics and Adverse Events Related to Antipsychotics in Children and Adolescents Enrolled in Mississippi Medicaid

    May 1, 2018, 00:00

  • Cost-Utility Analysis of Istent Trabecular Micro-Bypass Stent Versus Medications Only for Patients with Open-Angle Glaucoma in Colombia

    May 1, 2018, 00:00

  • Apixaban Compared With Low Molecular Weight Heparins For Prophylaxis In The Patients At Risk Of Venous Thromboembolism- A Systematic Review And Meta-Analysis

    May 1, 2018, 00:00

  • Web-Based Computerized Adaptive Testing Via An Open-Source Platform

    May 1, 2018, 00:00

  • Locally Advanced Or Metastatic Urothelial Carcinoma In The United States- Economic Burden And Healthcare Utilization

    May 1, 2018, 00:00

  • Patient Reported Outcomes In Metastatic Renal Cell Carcinoma Patients Receiving Pazopanib In A Community Oncology Setting

    May 1, 2018, 00:00

  • A Pilot Study on Cost Evaluation of Urgent Start Automated Peritoneal Dialysis and Hemodialysis in the Treatment of End-Stage Renal Disease in São Paulo, Brazil

    May 1, 2018, 00:00

  • Impact of Psychosocial Factors on Health Services Utilization and Cost of Care in Blood and Marrow Transplant Patients

    May 1, 2018, 00:00

  • Designing and Implementing A New Model of Nutrition Care for Hospitalized Colombian Patients

    May 1, 2018, 00:00

  • Biopsy Procedures in Patients with Primary Lung Cancer

    May 1, 2018, 00:00

  • Impact of Depression and Anxiety on the Quality of Life at the Population Level

    May 1, 2018, 00:00

  • Economic Value of Next Generation Sequencing Panels in Oncology - A Market Development Perspective

    May 1, 2018, 00:00

  • Assessing the Potential Impact of Treating Hyperphagia Among People With Prader-Willi Syndrome Using Disease-Specific Qalys

    May 1, 2018, 00:00

  • Therapy For Glioma- Indian Market Overview

    May 1, 2018, 00:00

  • Potential Budget Impact Of High-Cost Therapies With Potential For Expanded Indications

    May 1, 2018, 00:00

  • National Health and Nutrition Examination Survey (NHANES) Analysis of the USA'S Obese Population and Related Comorbidities

    May 1, 2018, 00:00

  • Real-World Healthcare Costs Based On Medication Adherence, Risk Of Stroke And Bleeding In Patients Treated With Novel Anticoagulant Therapy

    May 1, 2018, 00:00

  • Long-Term Cost-Effectiveness of Valbenazine and Deutetrabenazine For Tardive Dyskinesia

    May 1, 2018, 00:00

  • Cost-Effectiveness of Ceftolozane/Tazobactam Plus Metronidazole as Empiric Therapy for the Treatment of Complicated Intra-Abdominal Infections in Colombia

    May 1, 2018, 00:00

  • Using Aggregate Data to Proxy Individual-Level Characteristics in Health Services Research- 9-Digit Zipcode Vs. CENSUS Block Group

    May 1, 2018, 00:00

  • Patterns Of Second-Line (2L) Treatment For Metastatic Urothelial Cancer (MUC) In Canada

    May 1, 2018, 00:00

  • A Measure of Health-Related Quality of Life (HRQOL) Associated with Chronic Conditions Using EQ-5D-5L in Hong Kong Sar,China

    May 1, 2018, 00:00

  • Incorporating Homomorphically Encrypted Data in Studies of Real-World Evidence to Support Expanded Approvals of Cancer Treatments

    May 1, 2018, 00:00

  • Comparison of Methods to Estimate Disease-Related Cost in the Truven Marketscan Adminstrative Claims Database

    May 1, 2018, 00:00

  • Sizing of the Migraine Population Treated with Preventive Medications for Migraine

    May 1, 2018, 00:00

  • Patient Goup Experiences of Engagement in Health Technology Appraisals for Rare Disease Treatments - A Pilot Study in the UK

    May 1, 2018, 00:00

  • Economic Evaluation of Ramucirumab as Second-Line Chemotherapy for Previously Treated Advanced Gastric or Gastro-Oesophageal Junction Adenocarcinoma in China

    May 1, 2018, 00:00

  • Descriptive Analysis of Commercially Insured Adult Opioid Users in The United States without Cancer or Hospi 2007-2015

    May 1, 2018, 00:00

  • Transporting the Results of A Clinical Trial to a New Target Population

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Endometriosis- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Secukinumab Prescribing Patterns in Patients with Psoriatic Arthritis in the United States- Data from Secukinumab Service Request Forms

    May 1, 2018, 00:00

  • Economic Consequences of Clinically Important Deterioration in Patients with Chronic Obstructive Pulmonary Disease- Analysis of the Torch Study

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis Of Amisulpride And Olanzapine For Patients With Schizophrenia in China

    May 1, 2018, 00:00

  • Systematic Literature Review (SLR) Of Sequencing Of Anaplastic Lymphoma Kinase (ALK) Inhibitors In ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

    May 1, 2018, 00:00

  • Analysis of Social Media Data Using Qualitative Methods- Understanding Preferences and Perceptions of Biologic Medications Among Patients with Severe Asthma

    May 1, 2018, 00:00

  • The Application of Electronic Medical Records (EMRS) as a Virtual Comparator Arm in a Lung Cancer Clinical Trial

    May 1, 2018, 00:00

  • Efficiency Test of Injury Prevention Program Among Junior Female Handball Players

    May 1, 2018, 00:00

  • The Feasibility of Utilizing Pharmacogenomics-Based Testing Techniques in the Treatment of HIV/AIDS- A Systematic Review

    May 1, 2018, 00:00

  • Emergency Room Visits and Out of Pocket Expenditure Among Individuals Enrolled in a High Deductible Health Plan

    May 1, 2018, 00:00

  • Assessing the Burden of Disease-Associated Malnutrition Among Hospitalized Malnourished Colombian Patients with Heart and Lung Disease

    May 1, 2018, 00:00

  • Baseline Health Utility Scores in Subjects with Suspected Ocular Disease- An Interim Analysis of the Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

    May 1, 2018, 00:00

  • Budget Impact Analyses- Inconsistency and Bias in Choice of Reporting Measures

    May 1, 2018, 00:00

  • Development and Application of a Novel Patient-Reported Outcomes Instrument, The Psoriasis Symptoms and Signs Diary, Measuring Psoriasis Severity in Clinical Trials

    May 1, 2018, 00:00

  • Budget Impact Analysis of Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in Specialties Hospital In Ecuador

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Anti-Diabetic Regimens in T2DM Patients Unexpectedly Maintain Their Hypoglycemic Regimens for a Long Duration- A Retrospective Clinical Data Analysis Study

    May 1, 2018, 00:00

  • Comparing Rates and Reasons for Medication Non-Adherence Across Seventeen Disease Conditions, Three Modes of Administration, And two Frequencies of Administration, Using the Medication Adherence Reasons Scale (MAR-SCALE)

    May 1, 2018, 00:00

  • Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada

    May 1, 2018, 00:00

  • Healthcare Cost of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis

    May 1, 2018, 00:00

  • Opioid Overdose Risk Factors- A Matched Case Control Study in Mississippi Medicaid

    May 1, 2018, 00:00

  • Bilateral Treatment in Patients with Neovascular Age-Related Macular Degeneration- A Retrospective Cohort Study in the US

    May 1, 2018, 00:00

  • Opioid Analgesic Prescribing Related to Dental Visits in the Mississippi Medicaid Population

    May 1, 2018, 00:00

  • Identifying Adherence Barriers To Oral Endocrine Therapy (OET) Among Breast Cancer Patients

    May 1, 2018, 00:00

  • Quality Of Life Of Patients With Cancer Undergoing Chemotherapy In Belo Horizonte Hospitals

    May 1, 2018, 00:00

  • Difficulty of Measuring Dose Response Due to Unreliability of Days Supply in Administrative Claims Data

    May 1, 2018, 00:00

  • Combatting Rising Obesity in AMCP Dossiers? The New AMCP Dossier Format – Version 4.0

    May 1, 2018, 00:00

  • Biosimilar Infliximab Utilization After Patent Expiry- The Case of Colitis Ulcerosa and Rheumatoid Arthritis in Hungary

    May 1, 2018, 00:00

  • Patient Reported Outcomes in Psoriasis Treatment Decision Making- A Discrete Choice Experiment Survey of Dermatologists in the Us

    May 1, 2018, 00:00

  • Incidence of Hepatocellular Carcinoma and Extrahepatic Cancers Among HCV-Infected Patients in the Era of Direct-Acting Antivirals

    May 1, 2018, 00:00

  • Findings from the 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Student Interest Survey

    May 1, 2018, 00:00

  • Selective Serotonin Reuptake Inhibitors and Bone Mass Density

    May 1, 2018, 00:00

  • Efficacy and Safety of Atosiban in Pregnant Women Under Threat of Preterm Labor- Systematic Review

    May 1, 2018, 00:00

  • Factors Associated with Late Presentation for HIV Care Among Antiretroviral Therapy Clinic Registrants in Eastern Ghana- an Analytic Cross Sectional Study, 2013

    May 1, 2018, 00:00

  • The Zero Dollar Copay Disease Management Program- Lowering Healthcare Utilization in Patients with Diabetes

    May 1, 2018, 00:00

  • Assessing the Cost-Effectiveness of Three-Monthly Paliperidone Palmitate Versus its Prior Monthly Formulation for the Management of Schizophrenia in the UK Setting

    May 1, 2018, 00:00

  • Cost-Effectivess Analysis of Brodalumab in Moderate-To-Severe Plaque Psoriasis in Canada

    May 1, 2018, 00:00

  • Comparative Safety of Sleep Prescriptions and Suicide Attempts in Veterans

    May 1, 2018, 00:00

  • Replicating and Extending the Four-Factor Structure of the Medication Adherence Reasons Scale (MAR-SCALE) in Pain, Migraine, And Sleep Conditions Among People Using Daily and Weekly Administered Oral Medications

    May 1, 2018, 00:00

  • Day-To-Day Fluctuations in Older Adults' Cognitive Functioning- Moving Beyond Single Time Point Assessments

    May 1, 2018, 00:00

  • The Current Landscape and Future of Outcomes-Based Contracting with Commercial Healthcare Payers in the US

    May 1, 2018, 00:00

  • Dengue Vaccine Efficacy- A Systematic Review

    May 1, 2018, 00:00

  • Cognitive Debriefing Interviews to Explore the Content Validity of the Chronic Liver Disease Questionnaire (CLDQ) and Eq-5D-5L in Patients with Chronic Hepatitis B

    May 1, 2018, 00:00

  • Role of Patient-Reported Outcome Evaluation in the Approval of Orphan Drugs- A Review of 15 Year Approvals by the FDA and the EMA

    May 1, 2018, 00:00

  • Community Oncology Perceptions And Views On Genomic Testing In The Era Of Precision Oncology

    May 1, 2018, 00:00

  • Approaches for Estimating the Comparative Efficacy of Treatments for Patients with Recurrent Small Cell Lung Cancer (SCLC) within Connected and Disconnected Networks of Evidence

    May 1, 2018, 00:00

  • Estimating the Lifetime Costs in Adult Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the United States

    May 1, 2018, 00:00

  • Development of a Conceptual Model and Review of Patient-And Observer-Reported Outcome Measures in Atopic Dermatitis

    May 1, 2018, 00:00

  • Economic Impact of Laparoscopic Vs Open Low Anterior Resection for Rectal Cancer Surgery- A Budget Impact Analysis

    May 1, 2018, 00:00

  • Medication Usage, Length of Stay and Hospital Charges in Schizophrenia Patients- A Retrospective Analysis of a Large US Electronic Health Record Database

    May 1, 2018, 00:00

  • Assessement of the Challenges Associated with Drug Innovation in Post-Traumatic Stress Disorder

    May 1, 2018, 00:00

  • Healthcare Resource Utilization and Costs in Patients with Persistent Asthma by Attainment of Healthcare Effectiveness and Data Information Set (HEDIS) Measures

    May 1, 2018, 00:00

  • Ablation Procedure Using Newer Radiofrequency Catheters (Thermocool® SF Catheter or Thermocool Smarttouch® Catheter) Versus Earlier Generation Thermocool® Catheter- A Real-World Comparison of Outcomes Using a us Hospital Database

    May 1, 2018, 00:00

  • How to Capture Authentic Patients' and Caregivers' Experience with Disease and Treatment- Establishing Trust with the "Gatekeepers" of Information

    May 1, 2018, 00:00

  • The Cost-Effectiveness of Treatments in Non-Cirrhotic Saudi Arabian Patients with Genotype 1 and Genotype 4 Chronic Hepatitis C

    May 1, 2018, 00:00

  • Shared Decision Making and Satisfaction with Care Among Patients with Diabetes Mellitus

    May 1, 2018, 00:00

  • Systematic Literature Review of Real-World Evidence on Persistence, Switching, and Dose Escalation with Biologics in Inflammatory Bowel Disease in the United States

    May 1, 2018, 00:00

  • Implications of Brexit on European Pharmaceutical Market Access

    May 1, 2018, 00:00

  • What are the Real Indirect Costs Associated with Multiple Myeloma- Model Patient Analysis From Slovak Republic

    May 1, 2018, 00:00

  • Differences in Antidepressant Medication Management Between Commercially Insured and Traditional Medicaid for Low Income Adults in Arkansas

    May 1, 2018, 00:00

  • Medication Use Before and after Hospitalization for COPD in a Cohort of Elderly Patients with Medicare Advantage Plan

    May 1, 2018, 00:00

  • College Students' Beliefs About Prescription Drug Misuse Among Peers

    May 1, 2018, 00:00

  • Estimating the Impact of Affordable Care Act (ACA) on Likelihood of Receiving Mammography and PAP Smear Screenings

    May 1, 2018, 00:00

  • Cost-Effectiveness Of Edoxaban Compared With Low Molecular Weight Heparin/Vitamin K Antagonist For The Treatment Of Venous Thromboembolism

    May 1, 2018, 00:00

  • The Benefits and Costs Of Different Scenarios for Varicella Vaccination in Chile

    May 1, 2018, 00:00

  • PRO2 Based Remote Monitoring in Ulcerative Colitis- A Prospective Real World Study

    May 1, 2018, 00:00

  • Taking The Burden Out Of Symptom Reporting In Patients With Melanoma Using A Digital Real-World Evidence Platform

    May 1, 2018, 00:00

  • Calculating Appropriate ICERS in Diabetes Prevention Program (DPP) Cost-Effectiveness and Overturning Misleading Conclusions Regarding Optimal Treatment

    May 1, 2018, 00:00

  • Salary Benchmarks and Compensation Disparity Among Global Health Economics and Market Access (HEORMA) Professionals Based on a 2017 Self-Report Survey

    May 1, 2018, 00:00

  • Benefits of Adenotonsillectomy in Children with Mild Obstructive Sleep Apnea Syndrome

    May 1, 2018, 00:00

  • Cost Per Responder Analysis of Guselkumab Versus Etanercept Using Efficacy Results from Pivotal Clinical Trials in Patients with Moderate to Severe Plaque Psoriasis

    May 1, 2018, 00:00

  • Budget Impact for Olaparib Maintenance Therapy for Brca-Mutated Platinum Sensitive Recurrent Ovarian Cancer in Panama

    May 1, 2018, 00:00

  • Clinical And Economic Burden Of Distributive Shock In US Intensive Care Units In 2014

    May 1, 2018, 00:00

  • An Algorithmic Approach To Optimal Study Design for Outcomes Research

    May 1, 2018, 00:00

  • The Prevalence and Predictors of Concomitant use of Tyrosine Kinase Inhibitors and Proton Pump Inhibitors in Older Adults with Cancer- An Observational Study Using Seer-Medicare Data

    May 1, 2018, 00:00

  • Cancer Mortality Trends In Brazil And Mexico

    May 1, 2018, 00:00

  • Drug Use Among Seniors in Canada, 2016

    May 1, 2018, 00:00

  • Evaluation of Opioid use Among Patients with Back Disorders and Arthritis

    May 1, 2018, 00:00

  • Estimated Reduction in Medication Cost During first Year of a Continuous Care Intervention for Treatment of Type 2 Diabetes

    May 1, 2018, 00:00

  • Economic Burden of Diagnosed Chronic Migraine and Diagnosed Episodic Migraine Patients in a Large US Health Insurer’s Population

    May 1, 2018, 00:00

  • Impact of Arkansas Medicaid Expansion Through Premium Purchase on the Utilization and Access to Prenatal Visits

    May 1, 2018, 00:00

  • Influence Factors and Economic Burden of Antidiabetics-Injection-Related Needle-Stick Injuries in China

    May 1, 2018, 00:00

  • Cost-Effectiveness of Edoxaban Compared with Dalteparin for the Treatment of Cancer-Associated Venous Thromboembolism

    May 1, 2018, 00:00

  • Emergency Care in Marfan Syndrome- A Retrospective Hospital Analysis

    May 1, 2018, 00:00

  • Economic Burden of Cardiometabolic Disorders Among Patients with Asthma

    May 1, 2018, 00:00

  • A Mapping And Analysis Of National Accelerated Access Pathways For Cancer Drugs

    May 1, 2018, 00:00

  • Setting the Boundaries for Economic Evaluation- Investigating Time Horizon and Family Effects in the Case of Postnatal Depression

    May 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of a First-in-Class, Triple Fixed Dose Combination Therapy Against Laba/Lama Therapy in Moderate-Severe COPD

    May 1, 2018, 00:00

  • Expanded Genomic Testing for Pediatric Cancers is Clinically Impactful But Reimbursement Lags Behind

    May 1, 2018, 00:00

  • A Review of the Costs of Lower Limb Amputations in Patients With Diabetes in the US

    May 1, 2018, 00:00

  • Comparative Analysis of Total Medical Expenditure of Therapy with Nebulized Budesonide and Systemic Corticosteroids for Patients with COPD Exacerbation

    May 1, 2018, 00:00

  • Economic Consequences of Anti-HCV Antiviral Treatment Investment from the NHS Perspective

    May 1, 2018, 00:00

  • Cost-Effectiveness of Serial Cervical Length Screening to Prevent Preterm Birth Among High-Risk U.S. Women- A Decision Analysis

    May 1, 2018, 00:00

  • Economic Analysis of Abaloparatide in High-Risk Postmenopausal Women with Osteoporosis in the United States - A Discrete-Event Simulation Model

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard of Care (SOC) for Acute Myeloid Leukemia (AML) in Canada

    May 1, 2018, 00:00

  • Challenges in Comparing Remission Outcomes in Network Meta-Analyses in Ulcerative Colitis

    May 1, 2018, 00:00

  • Drivers of Genomic Precision Medicine Adoption in the US- Payer Preferences

    May 1, 2018, 00:00

  • Graphical Probabilistic Models for Risk Prediction and Decision Making Using Real-World Data- A Developing Tool for the Era of Precision Medicine

    May 1, 2018, 00:00

  • Examining the Effect of Missing Data on the Acmg Newborn Screening Criteria of Least Consensus for Carnitine Palmitoyltransferase II Deficiency (CPTII)

    May 1, 2018, 00:00

  • Assessing Cellulite Severity- Method for Assessing Reliability of a New Clinician-Reported and a New Patient-Reported Photonumeric Scale

    May 1, 2018, 00:00

  • Positive Cancer Drug Recommendations By The Pan-Canadian Oncology Drug Review Are Not Without Conditions Placed On Cost-Effectiveness

    May 1, 2018, 00:00

  • A Systematic Review of Cost-Effectiveness Analysis Studies in Newborn Screening (NBS)

    May 1, 2018, 00:00

  • The Cost of Comorbid Depression Among Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • Calculating Rasch-Based Person Parameters for Individual Items

    May 1, 2018, 00:00

  • Assessment of the Use of Pharmacogenetics in the Diagnosis and Treatment of Schizophrenia- Results from a Survey of Psychiatrists

    May 1, 2018, 00:00

  • Utilization, Reimbursement, and Price of Incretin-Based and Peptides Therapies for Type 2 Diabetes in US Medicaid Program from 2005 to 2016

    May 1, 2018, 00:00

  • Incidence of Depression Following Traumatic Brain Injury

    May 1, 2018, 00:00

  • The Clinical Value of Early Diagnosis Tests for the Long-Term Management of Dementia

    May 1, 2018, 00:00

  • Use Of Biomarker Testing In Head And Neck Cancers In The United States And EU5

    May 1, 2018, 00:00

  • What is the Cost of a Breast Cancer Therapy Infusion? Real World Data on Brazilian Private Healthcare Perspective

    May 1, 2018, 00:00

  • The Association Between Anti-Epileptic Drug Adherence to Sodium Channel Blockers and Health-Related Quality of Life- Analysis of US Survey Data from Patients with Epilepsy

    May 1, 2018, 00:00

  • Cognitive and Mind-Body Therapies for the Treatment of Chronic Low Back Pain – A Cost-Effectiveness Analysis

    May 1, 2018, 00:00

  • Real-World Outcomes and Medication Adherence to Disease Modifying Therapies (DMTS) Among Patients with Multiple Sclerosis (MS)

    May 1, 2018, 00:00

  • Synthetic Sample Generation Representing the English Population Using Spearman Rank Correlation and Chomsky Decomposition

    May 1, 2018, 00:00

  • The Association Between Prescription Stimulant Use and Prescription Drug Misuse

    May 1, 2018, 00:00

  • Comparing Short Form – 6 Dimension (SF-6D) Derived Utilities and Euroqol Questionnaire – 5 Dimensions (EQ-5D) Mapped Utilities Among Patients with Iron Deficiency in Inflammatory Bowel Disease (ID-IBD) Treated with Ferric Maltol (FM) Vs Pla ...

    May 1, 2018, 00:00

  • Extended-Duration VTE Prophylaxis With Orally Administered Betrixaban Saves Cost Compared To Standard-Duration Enoxaparin Across The Inpatient And Outpatient Settings

    May 1, 2018, 00:00

  • Social Media Listening for Patient Risk Characterization

    May 1, 2018, 00:00

  • Developing A Consolidated Checklist (Strwe-Retro) to Assess the Reporting Quality of Real World Evidence Studies Based on Retrospective Data Analyses

    May 1, 2018, 00:00

  • Budget Impact Analysis of Palbociclib for the Treatment of Patients With HR+/HER2− Advanced/Metastatic Breast Cancer In Bulgaria

    May 1, 2018, 00:00

  • Transplanting Kidneys from HCV Positive Donors into HCV Negative Recipients in the Era of Direct Acting Antiviral Therapy- A Cost Effectiveness Analysis

    May 1, 2018, 00:00

  • Insurance Marketplace Enrollment and In-Person Assistance Under the Affordable Care Act

    May 1, 2018, 00:00

  • Increased Healthcare Utilization in Dementia Subtypes Prior to Diagnosis

    May 1, 2018, 00:00

  • Perceptions of Biosimilars Across Physician Specialities in Europe

    May 1, 2018, 00:00

  • Main Drivers of Direct Healthcare Costs for Osteoarthritis in The US- A Retrospective Private Insurance Claims Analysis Through 2014

    May 1, 2018, 00:00

  • Variation In Locoregional Treatment Of Stage I – II Breast Cancer By Breast Subtype In Nonelderly Adult Women

    May 1, 2018, 00:00

  • Implementation of the South African Triaging Scale (SATS) System in Eastern Ghana- Assessment of Deployment at the Emergency Department of a Regional Hospital, 2015

    May 1, 2018, 00:00

  • Effectiveness of Guideline-Recommended Care Bundles- A Systematic Review

    May 1, 2018, 00:00

  • Ablation Versus Antiarrhythmic Drug Treatment Among Patients with Atrial Fibrillation- A Propensity-Matched Analysis

    May 1, 2018, 00:00

  • Cost-Minimization Analysis of Tafluprost/Timolol Maleate for Lowering Intraocular Pressure (IOP) in Adult Patients with Open-Angle Glaucoma or Ocular Hypertension in Bulgaria

    May 1, 2018, 00:00

  • Optifast® Meal Replacement Program for the Treatment of Obesity- A Cost-Effectiveness Assessment from the Employer Perspective in the USA

    May 1, 2018, 00:00

  • Approvals and Pricing of Factor VIII and Factor IX Concentrates for Hemophilia A and B in the United States

    May 1, 2018, 00:00

  • A Dynamic Approach for Budget Impact Analysis (BIA) in Oncology- Nonmetastatic Castration-Resistant Prostate Cancer (NMCRPC) as an Illustrative Example

    May 1, 2018, 00:00

  • Duration of Treatment and Economic Burden in Patients with Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Receiving Second-Line Alk Inhibitors

    May 1, 2018, 00:00

  • Real World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Indian Patients with Functional Dyspepsia

    May 1, 2018, 00:00

  • Using Real-World Evidence for Health Technology Assessment Submissions- Lessons and Insights from Review Of Nice’s Technology Assessment Reports (2016-2017)

    May 1, 2018, 00:00

  • Cost-Effectiveness of Treating Romanian Post-Stroke Patients with Upper Limb Spasticity With Incobotulinumtoxin-A Against Conventional Therapy

    May 1, 2018, 00:00

  • Treatment Patterns and Economic Burden of Chinese Metastatic Colorectal Cancer Patients- a Retrospective Study of Electronic Medical Records from Urban China

    May 1, 2018, 00:00

  • A Retrospective Observational Study on Characteristics and Medical Resource Utilization of Long-Term Hospitalization Patients in China

    May 1, 2018, 00:00

  • Psychosocial and Other Non-Drug Treatments for Bipolar Disorder in Adults- A Systematic Review

    May 1, 2018, 00:00

  • The Humanistic Burden of Postpartum Depression- A Systematic Literature Review

    May 1, 2018, 00:00

  • Cost Effectiveness of Anti-PD-1/PD-L1 Treatments- Systematic Review of Published Studies

    May 1, 2018, 00:00

  • The Impact of Legislative Changes and Regulatory Guidance on Proactive Dissemination of Healthcare Economic Information- Payers’ Experiences Pre and Post Product Approval

    May 1, 2018, 00:00

  • Cost-Effectiveness of Donepezil in the Treatment of Patients With Alzheimer's Disease- An Update

    May 1, 2018, 00:00

  • Conversion of Hypoglycemia Utility Decrements from Categorical Units Reflecting Event History into Event Specific Disutility Scores Applicable to Diabetes Decision Models

    May 1, 2018, 00:00

  • The Impact of Ophthalmology in the Hungarian One-Day Surgery

    May 1, 2018, 00:00

  • Prostate Cancer Costs In Colombia- A Top-Down Approach

    May 1, 2018, 00:00

  • Incorporating Reimbursement and Health Economics (RHE) into the New Product Development Process

    May 1, 2018, 00:00

  • Efficacy and Safety of Fluticasone Furoate Nasal Spray for Perennial Allergic Rhinitis in Adults and Adolescents- A Systematic Review

    May 1, 2018, 00:00

  • Health Insurance Status and Outcomes Among Adults with Mycosis Fungoides in the United States

    May 1, 2018, 00:00

  • Determinants of Asthma in Children- Evidence from National Survey of Children’s Health in USA

    May 1, 2018, 00:00

  • An Economic Evaluation of a Familial Cancer Risk Management Program for Brca Mutation Carriers- An Australian Perspective

    May 1, 2018, 00:00

  • A Systematic Review of Discrete Choice Experiment and Conjoint Analysis in Measuring Patients’ Preferences for Multiple Sclerosis Treatments

    May 1, 2018, 00:00

  • Heart Rate Variability Testing- Could it Change Spending for Rheumatoid Arthritis Patients in the United States? An Exploratory Economic Analysis

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Hepatitis C Treatments in Mexico- Genotype 2 and 3

    May 1, 2018, 00:00

  • Septic Revision of All Knee Components Following Total Knee Arthroplasty- Type and Payments for Care, and Incidence of 1-Year Re-Infection and Amputation

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Universal Vs Targeted Human Immunodeficiency Virus (HIV) Screening Approaches to Identify New HIV Diagnoses in the Emergency Department (ED)

    May 1, 2018, 00:00

  • Personal Income Before and After Diagnosis of Multiple Sclerosis

    May 1, 2018, 00:00

  • Impact of Initiating Long-Acting Injectables on All-Cause and Psychiatric Hospitalization in Patients With Bipolar I Disorder

    May 1, 2018, 00:00

  • Cost-Effectiveness of Daclizumab Versus Interferon Beta-1A in the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis in the United States

    May 1, 2018, 00:00

  • Complications, Health Care Resource Utilization and Costs Associated with Type III Open Fractures of the Tibial Shaft Requiring Open Reduction and Internal Fixation

    May 1, 2018, 00:00

  • Can Severity Outweigh Smaller Numbers? A Deliberative Perspective from Canada

    May 1, 2018, 00:00

  • Analysis the Number of Cases of One-Day Surgical Patient Care in Hungarian University Clinical Centre’s Between 2010-2015

    May 1, 2018, 00:00

  • Utilizing Natural Language Processing and Machine Learning to Create a Better Member Experien Blue Cross Blue Shield of Louisiana (BCBSLA) Innovation in Action

    May 1, 2018, 00:00

  • A Systematic Review of Economic Outcomes Associated With Use of Topical Interventions for Treatment Of Chronic Wounds

    May 1, 2018, 00:00

  • Online Methods for the Electronic Validation of the Treatment Satisfaction for Medication Questionnaire

    May 1, 2018, 00:00

  • Cost-Effectiveness of Regular Utilization of Zoledronic Acid for Developed Bone Metastases from Advanced Breast Cancer in Chinese Patients

    May 1, 2018, 00:00

  • Racial Trends in Non-Vitamin/Non-Mineral Medication Use During Pregnancy or Puerperium in the Ambulatory Care Setting

    May 1, 2018, 00:00

  • The Impact of Response at A Landmark on Overall Survival- Implications for the Economic Evaluation of the Value of Immuno-Oncology (I-O) Treatment in Non-Small Cell Lung Cancer (NSCLC)

    May 1, 2018, 00:00

  • Association Between Age at Initiation of Regular Cigarette Smoking and Age at Initiation Of Substance Use- A Cohort Study

    May 1, 2018, 00:00

  • A Retrospective Analysis of Tack Use With Progrip™ Laparoscopic Self-Fixating Mesh and 3dmax™ Mesh in Outpatient Hospital Inguinal Hernia Repair Procedures

    May 1, 2018, 00:00

  • Accountable and Reasonable Processes for Coverage Decision-Making for Rare Disease and Regenerative Therapies – Which Criteria Should be Considered and Why?

    May 1, 2018, 00:00

  • Do Commercial Health Care Prices Influence Medicare Spending?

    May 1, 2018, 00:00

  • Costs of Hodgkin and Non-Hodgkin Lymphoma in Fran Results on the Basis of the French National Health Insurance Database

    May 1, 2018, 00:00

  • Current Management of Specialty Drugs, Specialty Pharmacies and Biosimilar Drugs

    May 1, 2018, 00:00

  • Psychometric Evaluation of the Psoriasis Symptoms Scale in Patients with Moderate to Severe Plaque Psoriasis

    May 1, 2018, 00:00

  • Complete Economic Evaluation of the Use of Micronized Progesterone By Vaginal Administration for the Prevention of Preterm Birth in Pregnant Patients with Short Cervix in Mexico

    May 1, 2018, 00:00

  • Adaption and Validation of the Adherence Barriers Questionnaire for HIV Patients with Antiretroviral Therapy

    May 1, 2018, 00:00

  • The Long-Term Benefits of Ensuring Timely Treatment and Improved Medication Adherence in Early Schizophrenia- A Microsimulation Study

    May 1, 2018, 00:00

  • A Case Management Approach to Reducing ER Visits- A Blue Cross Blue Shield of Louisiana (BCBLSA) Case Study

    May 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of Voretigene Neparvovec for Vision Loss Due to Biallelic Rpe65-Mediated Inherited Retinal Disease

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Primary Immunodeficiency- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Review of Operative Outcomes of Robotic Surgical Procedures Performed with Robotic vs. Endoscopic Linear Staplers

    May 1, 2018, 00:00

  • Recursively Imputed Survival Trees for Extrapolating Survival Beyond Clinical Trial Follow UP- A Simulation Study

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Hepatocellular Carcinoma (HCC)- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases

    May 1, 2018, 00:00

  • Prevalence of Latent Tuberculosis Infection in Patients with Rheumatoid Arthritis in Colombia- A Single Setting Study

    May 1, 2018, 00:00

  • Reimbursement of Vedolizumab According to the Indications- what are the Impacts in the 37 Public Hospitals of Paris?

    May 1, 2018, 00:00

  • Model-Based Network Meta-Analysis for Time Course Relationships- A Union of two Methodologies

    May 1, 2018, 00:00

  • A Work-Sampling Study of an Innovative Pediatric Care-Coordination Program for Asthma, Diabetes, and Sickle Cell Patients

    May 1, 2018, 00:00

  • Assessing Hospital Utilization of Patients Diagnosed with Marfan Syndrome

    May 1, 2018, 00:00

  • Patterns of Non-Adherence to Oral Antiviral Drugs

    May 1, 2018, 00:00

  • Relationship Between Early-Life Antibiotic Exposure and Childhood Obesity- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Self-Reported Insomnia Symptoms and Health Related Quality of Life in the US Adult Population

    May 1, 2018, 00:00

  • Economic Impact of Absenteeism and Deaths Due to Pneumonia in Brazilian Economy

    May 1, 2018, 00:00

  • Impact of Skeletal-Related Events on Anti-Tumor Therapy Pattern in Patients with Bone Metastases from Prostate Cancer

    May 1, 2018, 00:00

  • A Predictive Model to Identify Opioid-Induced Respiratory Depression Among Hospitalized Patients

    May 1, 2018, 00:00

  • The Effect of Medication Choice After Tumor Necrosis Factor Inhibitor (TNFI) use on the Healthcare Costs for Patients with Rheumatoid Arthritis- An Instrumental Variables Approach

    May 1, 2018, 00:00

  • How Will Payers Manage The High Cost Of Combinations Of New Oncology Agents, As Many Of These Therapies Become The Preferred Treatment Options To Optimize Patient Outcomes?

    May 1, 2018, 00:00

  • Association Between Bleeding Events and Health-Related Quality-of-Life in Adults with Severe Hamophilia A

    May 1, 2018, 00:00

  • Cost-Effectiveness of Crizotinib for First-Line Treatment in Non-Small Cell Lung Cancer in Ecuador

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Palbociclib for the Treatment of Patients with HR+/HER2− Advanced/Metastatic Breast Cancer in Bulgaria

    May 1, 2018, 00:00

  • Analytic Model to Estimate Costs of two Dialysis Modalities in Paraguay

    May 1, 2018, 00:00

  • Cost-Effectiveness of Paliperidone Palmitate Long-Acting Injectable Versus Oral Antipsychotics For The Treatment Of Patients With Schizophrenia In Peru

    May 1, 2018, 00:00

  • Cabozantinib Versus Standard of Care in the first-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Economic Burden of Non–Communicable Diseases (NCDS) In Poland

    May 1, 2018, 00:00

  • Belimumab for the Treatment of Adults Living with Active Systemic Lupus Erythematosus- A Cost-Effectiveness Analysis in Canada

    May 1, 2018, 00:00

  • Pharmacy Closures and Adherence to Cardiovascular Medications Among Older Adults in the U.S

    May 1, 2018, 00:00

  • A Retrospective Claims Analysis of Bronchodilator Monotherapy Versus Dual Bronchodilator Fixed-Dose Combination in Patients with COPD

    May 1, 2018, 00:00

  • Modifiable Risk Factors and Population Attributable Risk of Obesity Among High School Students in the U.S

    May 1, 2018, 00:00

  • Factors Related to Non-Integrated or Fragmentation Polypharmacy in A Colombian Population

    May 1, 2018, 00:00

  • Hospitalisation Rate as a Proxy Outcome for Clinical Value in a Protocolised Cancer Treatment Environment

    May 1, 2018, 00:00

  • Quantifying the Added Societal Value of Public Health Interventions in Reducing Health Inequality

    May 1, 2018, 00:00

  • The Zero Dollar Copay Disease Management Program- Lowering Healthcare Utilization In Patients With Chronic Diseases

    May 1, 2018, 00:00

  • Trends in Regional Variation Among Inpatients with Breast Cancer in the United States- Analysis of 2010-2014 Healthcare Cost and Utilization Project Data

    May 1, 2018, 00:00

  • Does The Traditional Hta Process Appropriately Evaluate Brand+Brand Oncology Combination Drugs?

    May 1, 2018, 00:00

  • US Payer Perspectives on Value and Comparisons Outside The US- An Interview Study

    May 1, 2018, 00:00

  • The Professionals’ Perspective of Patient Involvement in Market Access- A Descriptive Analysis

    May 1, 2018, 00:00

  • Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access- Case of PCSK9 Inhibitors

    May 1, 2018, 00:00

  • Systematic Literature Review (SLR) Of Health State Utility Values (HSUV) In Epidermal Growth Factor Receptor Mutant (Egfr-Mutant) Non-Small Cell Lung Cancer (NSCLC) Patients Previously Treated With Targeted Therapies

    May 1, 2018, 00:00

  • Study of Prevalence of Tobacco Use Among Children and Youth in India

    May 1, 2018, 00:00

  • A Critical Assessment Of The Role Of Health Outcomes Liaisons- Today And The Future

    May 1, 2018, 00:00

  • Real-World Data Analysis of Confirmatory Biopsy Utilization in Suspected Prostate Cancer Patients

    May 1, 2018, 00:00

  • The Growing Number Of High-Cost Advanced Therapy Medicinal Products (ATMPS) Pose Unprecedented Pricing And Funding Challenges To Current Models Of Healthcare

    May 1, 2018, 00:00

  • Association Between Insurance Type and Level of Care in Community-Living Patients with Alzheimer’s Disease and Related Dementias

    May 1, 2018, 00:00

  • Analysis of Success Rates for the Center for Medicare and Medicaid’s New Technology Add-On Payment Program

    May 1, 2018, 00:00

  • Is Medication Adherence A Mediator of the Relationship Between Race/Ethnicity and Healthcare Cost in Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • Applying Population Health Management Techniques to Lower Healthcare Utilization in Patients with Non-Chronic Complex Diseases

    May 1, 2018, 00:00

  • Prevalence and Factors Associated with Uptake of the 3-Dose Catch-UP Primary Series of the Tetanus-Diphtheria Vaccine in a Recently Resettled Refugee Population

    May 1, 2018, 00:00

  • Missing Data in Patient-Reported Outcomes- Regulatory, Statistical, and Operational Perspectives

    May 1, 2018, 00:00

  • Characteristics of Patients Receiving Dmard Therapy for Rheumatoid Arthritis Management

    May 1, 2018, 00:00

  • Medication Synchronization Improves Medication Adherence

    May 1, 2018, 00:00

  • Number Needed to Treat in Patients with Spinal Muscular Atrophy Type 1 Treated with Avxs-101 Relative to Nusinersen

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Rucaparib Maintenance Treatment for Recurrent Ovarian Carcinoma after Response to Platinum Therapy

    May 1, 2018, 00:00

  • Geographic Variation of High-Risk Opioid Use and Risk of Overdose Among Disabled Medicare Beneficiaries in the US from 2011 to 2015

    May 1, 2018, 00:00

  • Understanding Sepsis Recognition and Management in Emergency Room Settings to Improve Patient Outcomes

    May 1, 2018, 00:00

  • The Cost Effectiveness of Sealant Program Between Public and Private Hospital in Chiang Mai Thailand

    May 1, 2018, 00:00

  • Role of Patient Assistance Program (PAP) in Market Access and Outcomes- Insights from Systematic Literature Review (2013-2017)

    May 1, 2018, 00:00

  • Older Patients’ Perception to Deprescribing In Resource Limited Settings- A Cross Sectional Study in an Ethiopia University Hospital

    May 1, 2018, 00:00

  • Cost-Effectiveness of Therapeutic Drug Monitoring for Imatinib Administration in Patients with Chronic Myeloid Leukemia

    May 1, 2018, 00:00

  • A Standardized Cognitive Interview Approach to Ensure Quality in Caregiver-Recorded Videos of Duchenne Muscular Dystrophy Patients’ Physical Function for Clinical Evaluation

    May 1, 2018, 00:00

  • Estimating the Health State Utility of Patients with HER2– gBRCA+ Metastatic Breast Cancer Treated with Olaparib or Chemotherapy Via A Mapping Analysis of Eortc QLQ-C30 Data Collected in the Olympiad Clinical Trial

    May 1, 2018, 00:00

  • Systematic Review and Network Meta-Analysis of Approved Medicines for the Treatment of Idiopathic Pulmonary Fibrosis

    May 1, 2018, 00:00

  • Long-Term Effectiveness of a Gambling Intervention Program Among Children in Central Illinois

    May 1, 2018, 00:00

  • Association Between Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and Lower Extremity Amputation- A Retrospective Cohort Study

    May 1, 2018, 00:00

  • Prescription Opioid Use Before and after An Overdose Event in Mississippi Medicaid

    May 1, 2018, 00:00

  • Natural Language Processing Methods Enhance Mace Identification from Electronic Health Records

    May 1, 2018, 00:00

  • Extending Inferences from Randomized Participants to All Eligible Individuals Using Clinical Trials Nested Within Cohorts

    May 1, 2018, 00:00

  • Caregiver Burden Among Individuals Providing Informal Caregiving to Survivors of Major Adverse Cardiac Event (MACE)- A Systematic Review

    May 1, 2018, 00:00

  • Aligned Strategies Identified by Prescribers and Managed Care to Close Treatment Decision Gaps in HCV and HIV

    May 1, 2018, 00:00

  • An Observational Study of Ivacaftor in Patients with Cystic Fibrosis and Selected Non-G551D Gating Mutations in UK, Italy and Netherlands- Healthcare Resource Utilization from the First Interim Analysis of the Vocal Study

    May 1, 2018, 00:00

  • Do Words Matter? Patient Perspetives on Conceptually Similar Symptoms and Impacts Frequently Utilized in Patient-Reported Outcome (PRO) Measures

    May 1, 2018, 00:00

  • Reduction In Hospitalizations and Medical Cost Savings Associated with Early use of Adjunctive Atypical Antipsychotics in Major Depressive Disorder

    May 1, 2018, 00:00

  • Cost-Effectiveness Of Rivaroxaban Versus Warfarin For Treatment Of Nonvalvular Atrial Fibrillation In Patients With Worsening Renal Function

    May 1, 2018, 00:00

  • Healthcare Utilization of Metformin in Patients with Type 2 Diabetes and Either Congestive Heart Failure, Liver Impairment or Renal Impairment

    May 1, 2018, 00:00

  • Projecting survival with cure mixture models- when are the data mature enough for reliable analysis?

    May 1, 2018, 00:00

  • Trends in HTA Submissions for Rare Diseases- Insights from Review of Nice’s Highly Specialized Technology (HST) Assessment Reports

    May 1, 2018, 00:00

  • Quantifying the Importance of Model Parameters and Structural Assumptions on the Value of Treatments for Rheumatoid Arthritis Using Metamodeling

    May 1, 2018, 00:00

  • Mothers’ Preferences and Willingness to Pay for Human Papillomavirus Vaccination for Their Daughters- A Discrete Choice Experiment in Hong Kong

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Daclatasvir in Combination with Asunaprevir (DUAL) for the Treatment of Chronic Hepatitis C Patients in China

    May 1, 2018, 00:00

  • Core Outcome Sets in Clinical Research- What are They and How Can they Help Decision Makers?

    May 1, 2018, 00:00

  • Hospital Lenght of Stay and Costs In Patients with Urinary Track Infections- Analysis of US National In-Patient Data for 2015 Using ICD-9 and ICD-10 Diagnoses

    May 1, 2018, 00:00

  • A Large-Scale Cross-Sectional Survey on Needle-Stick Injuries Related to Injections of Antidiabetics in China- Incidence and Infection Rates

    May 1, 2018, 00:00

  • Vost Effectiveness of Blinatumomab Vs Inotuzomab Ozogamicin (INOTUZUMAB) in Adult Patients with Relapsed or Refracory (R/R) Acute Lymphoblastic Leukemia (ALL) with Zero or One Prior Salvage Therapy (S0/S1) from a US Payer Perspective

    May 1, 2018, 00:00

  • Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1- A Canadian Cost-Utility Analysis

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Smoking Cessation Interventions in Malaysia

    May 1, 2018, 00:00

  • Economic Impact of French Public Regulations on Ferric Carboxymaltose in 39 Paris Public Hospitals Over the 2013-2016 Period

    May 1, 2018, 00:00

  • Analysis of Health Insurance Coverage by Citizenship Status in the United States

    May 1, 2018, 00:00

  • Biosimilars- Barriers and Opportunities to Market Access in the United States

    May 1, 2018, 00:00

  • Predictive Model for Earlier Diagnosis of Dementia Using Administrative Claims

    May 1, 2018, 00:00

  • Evaluation of Potentially Inappropriate Medications and Clinical Outcomes in Older Adults Admitted to the Medical Intensive Care Unit

    May 1, 2018, 00:00

  • Nutritional Situation in Under – 5 in “Montes De Maria”, Post-Conflict Zone in Colombia- 2017

    May 1, 2018, 00:00

  • The Economic Burden of Skin Symptoms in Psoriatic Arthritis

    May 1, 2018, 00:00

  • Racial/Ethnic Disparity in HRQoL- Implications of Social Support and Social Connectedness in Thyroid Cancer Care

    May 1, 2018, 00:00

  • Geographic Variation in Utilization of Physician Services Among Older Adults Diagnosed with Non-Hodgkin Lymphoma

    May 1, 2018, 00:00

  • Cost-Effectiveness of Ceftolozane/Tazobactam as Empiric Therapy for the Treatment of Complicated Urinary Tract Infections in Colombia

    May 1, 2018, 00:00

  • An Analysis of the Applications for Confirmation on Whether to Belong to the Subjects of the New Health Technologies Assessment in Korea

    May 1, 2018, 00:00

  • Cost Analysis Of Lipid Goal Attainments And Their Relationship With Clinical Outcomes In Chinese Post-Percutaneous Coronary Intervention Acute Coronary Syndrome Patients

    May 1, 2018, 00:00

  • A Prospective Clinical Observational Study on Assessment of Risk Factors, Diagnosis and Prescribing Patterns of Medications for Migraine

    May 1, 2018, 00:00

  • A Comparison Of Patient And Caregiver Worries For Acute Myeloid Leukemia

    May 1, 2018, 00:00

  • Impact of Distal Radius Sterile KIT on Provider Budget in the USA

    May 1, 2018, 00:00

  • Patient Access to Medicines for Rare Diseases in European Countries

    May 1, 2018, 00:00

  • Symptoms And Impacts In Advanced/Metastatic Gastric Or Gastroesophageal Junction Cancer- Findings From Qualitative Patient Interviews

    May 1, 2018, 00:00

  • Inpatient Cost and Complications of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Hodgkin’s Lymphoma (NHL)

    May 1, 2018, 00:00

  • Free-Flap Mandibular Reconstructions- Patient Demographics And Resource Utilization in the United States

    May 1, 2018, 00:00

  • Medical Resource Utilization and Expenditures in Texas Medicaid Patients Taking Deferasirox Dispersible Tablets and Those Taking Deferasirox Film-Coated Tablets

    May 1, 2018, 00:00

  • Shared Decision-Making in Children and Adolescents with Mental Health Conditions

    May 1, 2018, 00:00

  • Self-Reported Experiences of Gender, Race, And Immigration Related Discrimination in Health Economics, Outcomes Research, And Market Access Professions

    May 1, 2018, 00:00

  • Barbec(EU)D Oncology Market Access – Part D(EU)X

    May 1, 2018, 00:00

  • Effect of Depression on Adherence to Controller Medications and Healthcare Resource Utilization in Asthma Patients

    May 1, 2018, 00:00

  • Cost-Effectiveness of Niraparib Versus Routine Surveillance and Olaparib for the Maintenance Treatment of Adult Patients with Ovarian Cancer in the United States

    May 1, 2018, 00:00

  • Availability of Pharmacies Participating in the 340B Drug Pricing Program, 2016

    May 1, 2018, 00:00

  • Cost-Effectiveness of Short-Course Radiotherapy Compared to Long-Course Chemoradiotherapy in the Treatment of Stage Iii Rectal Cancer Patients from the US Societal Perspective

    May 1, 2018, 00:00

  • Direct Costs Associated with Multiple Myeloma Model Patient in 2017 From Single EU Jurisdiction

    May 1, 2018, 00:00

  • Impact of the Hitech Act’s Incentive Program on the Adoption of Drug-Drug Interaction Alerts and Electronic Prescribing in the Ambulatory Care Setting

    May 1, 2018, 00:00

  • Is the Orphan Drug Act Being used as a Loophole to Extend Periods of Drug Exclusivity?

    May 1, 2018, 00:00

  • Accepting Biosimilars - what are the Doctors Looking for? - A Systematic Review

    May 1, 2018, 00:00

  • Reasons for Non-Adherence with Statins Among Patients Who Had a Primary Cardiovascular Disease Event

    May 1, 2018, 00:00

  • Asthma-COPD Overlapping as a Risk Factor for Healthcare Utilizations Among Adults with Asthma

    May 1, 2018, 00:00

  • Patient-Reported Outcome Use And Completion Information In Non-Randomized Cancer Trials

    May 1, 2018, 00:00

  • A Hospital Budget Impact Model to Estimate the Impact Associated with Phasix™ and Phasix™ St Mesh Versus Stratticetm Matrix in Complex Ventral Hernia Repair Procedures

    May 1, 2018, 00:00
  • «
  • 61
  • 62 (current)
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • »